Panhematin (Hemin for Injection)

Panhematin is a hemin for injection used for amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women, after initial carbohydrate therapy is known or suspected to be inadequate.

Limitations of Use: Before administering Panhematin, consider an appropriate period of carbohydrate loading (i.e., 400 g glucose/day for 1 to 2 days). This treatment is not effective in repairing neuronal damage because of the progression of porphyria attacks.

Recommended Dosage:

The recommended dosage of Panhematin is 1 to 4 mg/kg/day administered via intravenous (IV) infusion only for 3 to 14 days, depending on the clinical signs. The standard dose in clinical practice is 3 to 4 mg/kg/day. Repeat dose in more life-threatening cases, no earlier than every 12 hours. Do not exceed 6 mg/kg in any 24-hour period.

• Panhematin is administered intravenously. It may cause vein irritation or phlebitis. Monitor the infusion site carefully. Rotate injection sites if needed. Slow the infusion rate to minimize discomfort and prevent local vascular complications during treatment.
• Panhematin contains heme, which can affect iron levels. Regularly monitor serum ferritin and iron parameters during treatment. Patients with iron overload or a history of hemochromatosis should be evaluated carefully before initiating therapy to prevent worsening iron-related complications.
• Panhematin may alter blood coagulation. Monitor patients on anticoagulants closely, as dosage adjustments may be needed. Watch for unusual bleeding, bruising, or prolonged clotting times. Notify healthcare providers immediately if any abnormal hemorrhage occurs during therapy.
• Panhematin can impact kidney function. Monitor renal parameters such as serum creatinine and urine output. Patients with pre-existing renal impairment should receive Panhematin cautiously. Adjust dosage or infusion schedule if renal function declines during treatment to avoid toxicity.
• As Panhematin is derived from human blood, there is a risk of viral or bacterial contamination. Ensure it is obtained from screened donors and follow proper storage. Report any signs of infection immediately to prevent complications.
• The safety of Panhematin during pregnancy is not fully established. Use only if the benefits outweigh potential risks to the fetus. Monitor maternal and fetal health closely. Avoid unnecessary exposure, and consult obstetric specialists for individualized care during treatment.
• It is unknown whether Panhematin passes into breast milk. Exercise caution when administering to nursing mothers. Consider temporary interruption of breastfeeding or alternative feeding options. Monitor the infant for any adverse effects if therapy is necessary for the mother.

What documents are required to import PANHEMATIN to India?

PANHEMATIN (Hemin for injection) injection can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is PANHEMATIN available in India?

PANHEMATIN (Hemin for injection injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Panhematin in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

PANHEMATIN can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of PANHEMATIN (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | or write us at info@indianpharmanetwork.in for Panhematin 350 mg injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source PANHEMATIN (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Panhematin®?

Hemin for injection is the Generic Name for the trade name drug Panhematin®.

What is the Manufacturer’s Name of Panhematin®?

Panhematin® is manufactured by Recordati Rare Diseases Inc.

Is Panhematin approved by the FDA?

Yes. Panhematin is approved by the FDA. date of first approval: July 20, 1983.

What is the dosage and form of Panhematin® supplied?

Panhematin is supplied as a sterile, lyophilized powder for reconstitution for injection. Each vial contains the equivalent of 350 mg hemin, 240 mg sodium carbonate, and 335 mg of sorbitol for intravenous infusion only.

What are the most common side effects of Panhematin® 350 mg injection?
The most commonly reported side effects of Panhematin® are infusion site reactions, headache, pyrexia, and phlebitis.

How much does Panhematin® 350 mg injection cost in India?

Panhematin® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Panhematin prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Panhematin 350 mg cost in India, please call/WhatsApp +91-9310090915 or send an email to info@indianpharmanetwork.in.

Can Panhematin® 350 mg injections be available in SAARC countries?

Apart from Gulf countries, Panhematin® can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Panhematin® injection in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Panhematin® 350 mg injection online in India?

Yes, one can buy Panhematin 350 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the legal supply of Panhematin® injection through legal channels.

What are the storage conditions of Panhematin® 350 mg injections?

Store lyophilized powder of Panhematin® at temperature 20°C to 25°C (68°F to 77°F).